|
2022
|
Invention
|
Improved treatments for advanced/metastatic cancers with checkpoint inhibitor resistance or resis... |
|
|
Invention
|
Anti-neoplastic combinations and dosing regimens using cdk4/6 inhibitor compounds to treat rb-pos... |
|
|
Invention
|
Combination treatments in patients with advanced and/or metastatic trop-2 overexpressed cancers. ... |
|
2021
|
Invention
|
Treatments for advanced and/or metastatic triple negative breast cancer. This invention is in the... |
|
|
Invention
|
Improved fluorouracil-based multi-agent chemotherapy for treatment of metastatic colorectal cance... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for use in oncology, improving outcomes ... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
use in oncology, improving outcomes... |
|
|
Invention
|
Morphic forms of trilaciclib and methods of manufacture thereof. An advantageous isolated morphic... |
|
|
Invention
|
Cyclin-dependent kinase inhibiting compounds for the treatment of medical disorders. This inventi... |
|
|
Invention
|
Therapeutic regimens for treatment of cancer using eribulin and selective cdk4/6 inhibitor combin... |
|
|
G/S
|
Health insurance information, namely, providing information regarding prescription drug insurance... |
|
|
Invention
|
Benzothiophene estrogen receptor modulators to treat medical disorders.
This invention is a benz... |
|
|
G/S
|
Pharmaceutical preparations for myeloprotection and anti-tumor effects; pharmaceutical preparatio... |
|
|
Invention
|
Cdk inhibitors.
Compounds of Formulae I, II or III, and pharmaceutically acceptable salts thereo... |
|
|
G/S
|
pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatm... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatm... |
|
2020
|
Invention
|
Transient protection of hematopoietic stem and progenitor cells against ionizing radiation.
This... |
|
|
Invention
|
Pyrimidine-based antiproliferative agents.
This invention is in the area of pyrimidine-based com... |
|
|
Invention
|
Targeted treatment of cancers with dysregulated fibroblast growth factor receptor signaling. The ... |
|
|
Invention
|
Treatment of cancers having driving oncogenic mutations.
Methods and compositions are described ... |
|
|
Invention
|
Highly active anti-neoplastic and anti-proliferative agents.
This invention is in the area of im... |
|
|
Invention
|
Heterocyclic compounds for the treatment of abnormal cellular proliferation.
This invention is i... |
|
|
Invention
|
Patient selection for enhancement of anti-tumor immunity in cancer patients. A method for increas... |
|
|
Invention
|
Antiproliferative pyrimidine-based compounds.
This invention is in the area of pyrimidine-based ... |
|
|
Invention
|
Pyrimidine-based compounds for the treatment of cancer.
This invention is in the area of pyrimid... |
|
|
Invention
|
Cell cycle inhibiting compounds for the treatment of medical disorders. This invention is in the ... |
|
|
Invention
|
Treatment of cdk4/6 inhibitor resistant neoplastic disorders. This invention is to methods for tr... |
|
2019
|
Invention
|
Improved synthesis of 1,4-diazaspiro[5.5]undecan-3-one. This invention provides a process for pre... |
|
|
Invention
|
Benzothiophene estrogen receptor modulators to treat medical disorders. This invention is a benzo... |
|
|
Invention
|
Cdk inhibitors for the treatment of neoplastic disorders. This invention is in the area of pyrimi... |
|
|
Invention
|
Treatment of cancers having driving oncogenic mutations. Methods and compositions are described t... |
|
|
Invention
|
G1t38 superior dosage regimes. A G1T38 human oral dosage regime that provides a (mean AUC(0-24),s... |
|
|
Invention
|
Heterocyclic compounds for the treatment of abnormal cellular proliferation. This invention is in... |
|
2018
|
Invention
|
Morphic forms of git38 and methods of manufacture thereof. This invention provides an unexpectedl... |
|
|
Invention
|
Morphic forms of g1t38 and methods of manufacture thereof. This invention provides an unexpectedl... |
|
|
Invention
|
Treatment of egfr-driven cancer with fewer side effects. The present invention provides methods f... |
|
|
Invention
|
Benzothiophene estrogen receptor modulators. This invention is a benzothiophene estrogen receptor... |
|
|
Invention
|
Combination therapy for the treatment of cancer. Compositions, combinations and methods comprisin... |
|
2017
|
Invention
|
Preservation of immune response during chemotherapy regimens. The addition of a selective, fast-a... |
|
|
Invention
|
Pyrimidine-based antiproliferative agents. This invention is in the area of pyrimidine-based comp... |
|
|
Invention
|
Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines. This invention is in the area of sy... |
|
|
Invention
|
Pyrimidine-based compounds for the treatment of cancer. This invention is in the area of pyrimidi... |
